Medical insurance reimbursement policy for avatrombopag (Avatrombopag, Sucoxin)

Avatrombopag/Avatrombopag has been included in the scope of medical insurance reimbursement and is a Class B drug in medical insurance. This means that patients can enjoy certain medical insurance reimbursement when purchasing the drug. However, the specific reimbursement ratio will vary by region. In addition, financial subsidy policies vary in different regions, which further affects the actual payment amount of patients. Therefore, in order to accurately understand the medical insurance reimbursement status of avatrombopag, patients are recommended to consult their local medical insurance agency or professional doctor to obtain the most detailed and accurate information. Overall, the medical insurance reimbursement policy for avatrombopag has reduced the financial burden on patients, allowing more patients to afford this effective treatment.